<DOC>
	<DOC>NCT00757848</DOC>
	<brief_summary>The purpose of this study is to investigate if treatment with AZD9668 for 28 days is effective in treating Cystic Fibrosis (CF) and if so how it compares to placebo (a substance which does not have any action).</brief_summary>
	<brief_title>A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Male or postmenopausal or surgically sterile female patients Have a clinical diagnosis of Cystic Fibrosis with lung function tests greater or equal to 40% of normal Have normal renal function Lung transplant patients Significant liver disease Any other nonCFrelated lung disease that may interfere with study assessments</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>cystic fibrosis</keyword>
</DOC>